Table 1: The phagoburst response of neutrophils from the healthy immunocompetent individual and the immunodeficient patients stimulated separately with E. coli, clinical and control A. baumannii isolates.

Source of neutrophils Negative
Control
Stimulus
E.coli
Positive control
Clinical A. baumannii isolates Septicemic Control ATCC BAA 1710 Non-septicemic Control ATCC BAA 747
Septicemic Non-septicemic
Blood
Nasal
Urine
No.1 No.2 No.3 No.1 No.2 No.3 No.1 No.2 No.3 No.4
Healthy individual 4.5 99.7 80.0 76.1 79.1 83.0 84.8 67.0 85.3 73.0 74.0 75.2 69.8 88.0
CML Patient 1.2 96.7 34.0 43.0 40.0 67.0 61.0 53.0 68.0 64.3 69.0 70.0 53.5 71.0
ST Patient 2.5 61.5 28.0 32.0 30.0 52.0 51.0 35.0 54.0 42.0 40.0 54.0 34.0 45.0

No.: Number; CML: chronic myeloid leukemia; ST: solid tumor.